Notis McConarty Edward Boosts Position in AptarGroup, Inc. $ATR

Notis McConarty Edward grew its stake in AptarGroup, Inc. (NYSE:ATR) by 0.8% in the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 37,329 shares of the industrial products company’s stock after buying an additional 296 shares during the quarter. AptarGroup makes up 2.8% of Notis McConarty Edward’s portfolio, making the stock its 13th biggest holding. Notis McConarty Edward’s holdings in AptarGroup were worth $5,839,000 as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds and other institutional investors have also bought and sold shares of the company. Focus Partners Wealth increased its position in AptarGroup by 94.4% in the first quarter. Focus Partners Wealth now owns 65,871 shares of the industrial products company’s stock worth $9,774,000 after buying an additional 31,985 shares in the last quarter. Simplex Trading LLC increased its position in AptarGroup by 107.4% in the first quarter. Simplex Trading LLC now owns 224 shares of the industrial products company’s stock worth $33,000 after buying an additional 116 shares in the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC increased its position in AptarGroup by 8.7% in the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 228,066 shares of the industrial products company’s stock worth $33,840,000 after buying an additional 18,315 shares in the last quarter. Royal Bank of Canada increased its position in AptarGroup by 4.8% in the first quarter. Royal Bank of Canada now owns 131,284 shares of the industrial products company’s stock worth $19,480,000 after buying an additional 6,031 shares in the last quarter. Finally, Avantax Advisory Services Inc. increased its position in AptarGroup by 18.2% in the first quarter. Avantax Advisory Services Inc. now owns 2,256 shares of the industrial products company’s stock worth $335,000 after buying an additional 348 shares in the last quarter. Hedge funds and other institutional investors own 88.52% of the company’s stock.

Insider Buying and Selling

In other AptarGroup news, insider Shiela Vinczeller sold 1,167 shares of the company’s stock in a transaction that occurred on Friday, September 5th. The stock was sold at an average price of $137.97, for a total transaction of $161,010.99. Following the sale, the insider directly owned 25,134 shares in the company, valued at $3,467,737.98. This represents a 4.44% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at this link. Also, insider Gael Touya sold 2,500 shares of the company’s stock in a transaction that occurred on Thursday, September 11th. The shares were sold at an average price of $136.12, for a total value of $340,300.00. Following the sale, the insider owned 31,463 shares in the company, valued at approximately $4,282,743.56. This trade represents a 7.36% decrease in their ownership of the stock. The disclosure for this sale can be found here. 0.68% of the stock is currently owned by corporate insiders.

AptarGroup Price Performance

Shares of AptarGroup stock opened at $131.57 on Thursday. The stock has a 50 day moving average of $137.15 and a 200 day moving average of $147.10. AptarGroup, Inc. has a 12 month low of $129.81 and a 12 month high of $178.03. The firm has a market cap of $8.67 billion, a PE ratio of 22.65, a PEG ratio of 2.69 and a beta of 0.55. The company has a current ratio of 1.21, a quick ratio of 0.83 and a debt-to-equity ratio of 0.20.

AptarGroup (NYSE:ATR) last announced its quarterly earnings results on Thursday, July 31st. The industrial products company reported $1.66 EPS for the quarter, beating analysts’ consensus estimates of $1.58 by $0.08. AptarGroup had a return on equity of 15.39% and a net margin of 10.84%.The company had revenue of $966.01 million during the quarter, compared to analyst estimates of $954.06 million. During the same period in the prior year, the company earned $1.41 earnings per share. The firm’s revenue was up 6.1% on a year-over-year basis. AptarGroup has set its Q3 2025 guidance at 1.530-1.610 EPS. On average, research analysts expect that AptarGroup, Inc. will post 5.57 EPS for the current fiscal year.

AptarGroup Increases Dividend

The company also recently declared a quarterly dividend, which will be paid on Thursday, November 13th. Investors of record on Thursday, October 23rd will be paid a dividend of $0.48 per share. The ex-dividend date of this dividend is Thursday, October 23rd. This is a boost from AptarGroup’s previous quarterly dividend of $0.45. This represents a $1.92 dividend on an annualized basis and a yield of 1.5%. AptarGroup’s dividend payout ratio is currently 33.05%.

Analysts Set New Price Targets

A number of brokerages have commented on ATR. Wells Fargo & Company reduced their price target on AptarGroup from $153.00 to $152.00 and set an “overweight” rating for the company in a research report on Wednesday, September 10th. KeyCorp initiated coverage on AptarGroup in a research note on Wednesday, September 3rd. They issued an “overweight” rating and a $220.00 price objective for the company. Weiss Ratings lowered AptarGroup from a “buy (b-)” rating to a “hold (c+)” rating in a research note on Wednesday. Finally, Raymond James Financial reaffirmed an “outperform” rating and issued a $172.00 price objective (down previously from $182.00) on shares of AptarGroup in a research note on Monday, August 4th. One investment analyst has rated the stock with a Strong Buy rating, five have given a Buy rating and two have given a Hold rating to the company. According to MarketBeat.com, AptarGroup has a consensus rating of “Moderate Buy” and an average target price of $182.00.

AptarGroup Profile

AptarGroup, Inc designs and manufactures a range of drug delivery, consumer product dispensing, and active material science solutions and services for the pharmaceutical, beauty, personal care, home care, and food and beverage markets. The company operates through Aptar Pharma, Aptar Beauty, and Aptar Closures segments.